Best Melanotan-2 for Libido: Purity Comparison
Choosing research-grade Melanotan-2 means evaluating synthesis method, purity verification, storage conditions, and supplier transparency. The table below compares what separates pharmaceutical-grade MT2 from typical grey-market alternatives. Research-Grade (R
This comparison does not assign a generated winner or score.
- Choosing research-grade Melanotan-2 means evaluating synthesis method, purity verification, storage conditions, and supplier transparency. The table below compares what separates pharmaceutical-grade MT2 from typical grey-market alternatives.
- Research-Grade (Real Peptides)
- Solid-phase peptide synthesis, exact amino-acid sequencing, lyophilized within hours of synthesis
- ≥98% HPLC-verified, endotoxin tested <1 EU/mg, amino acid sequencing confirmed
- Stored at −20°C, shipped with cold chain packaging, guarantees stability during transit
- Consistent MC4R activation, predictable dose-response, minimal synthesis impurities. Clinical-trial equivalency
- Grey-Market 'Pharmaceutical Grade'
- Solid-phase synthesis (claimed), lyophilization timing unspecified
- 95–99% purity claimed, HPLC provided at synthesis (not at sale), no endotoxin testing
- Typically stored at room temp in warehouses, shipped without cold packs, degradation during storage common
- Purity variance 78–96% in third-party testing, inconsistent results, higher nausea rates due to degradation byproducts
- Underground/Homebrew
- Synthesis method unverified, often bulk powder repackaged
- Purity unverified, no HPLC provided, often relabeled research chemicals
- No cold storage, no sterile handling, shipped ambient temperature
- High contamination risk, unpredictable potency, frequent reports of no effect or severe nausea. Not suitable for controlled research
- The bottom line: MT2 below 98% purity isn't just weaker. It contains competitive inhibitors that block receptor activation. Real Peptides' small-batch synthesis and cold chain guarantee mean the MT2 you reconstitute performs the way published trials described.